TTP to symptomatic myeloma stratified based on risk factors (immunoparesis, eHb GBTM, eMP GBTM, and edFLC GBTM). The median times to progression for 0, 1, 2, or ≥3 risk factors were not reached: 77, 26, and 13 months, respectively (P <.0001).